

Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
The global Reverse Transcriptase market is projected to grow from US$ 335 million in 2024 to US$ 419 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.8% during the forecast period.
Thermo Fisher, Promega, Roche, Bio-Rad and Takara Bio are the main producers of Reverse Transcriptase, the top 3 hold nearly 40% of the whole market. North America is the main market, which holds about 40% of the global marketshare.
Report Covers:
This report presents an overview of global market for Reverse Transcriptase, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Reverse Transcriptase, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Reverse Transcriptase, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Reverse Transcriptase sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Reverse Transcriptase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Reverse Transcriptase sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs
Segment by Type
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Segment by Application
PCR
Sequencing
Cloning
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Reverse Transcriptase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Reverse Transcriptase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Reverse Transcriptase sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Reverse Transcriptase Product Introduction
1.2 Market by Type
1.2.1 Global Reverse Transcriptase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 MMLV Reverse Transcriptase
1.2.3 AMV Reverse Transcriptase
1.3 Market by Application
1.3.1 Global Reverse Transcriptase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 PCR
1.3.3 Sequencing
1.3.4 Cloning
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Reverse Transcriptase Sales Estimates and Forecasts 2019-2030
2.2 Global Reverse Transcriptase Revenue by Region
2.2.1 Global Reverse Transcriptase Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Reverse Transcriptase Revenue by Region (2019-2024)
2.2.3 Global Reverse Transcriptase Revenue by Region (2025-2030)
2.2.4 Global Reverse Transcriptase Revenue Market Share by Region (2019-2030)
2.3 Global Reverse Transcriptase Sales Estimates and Forecasts 2019-2030
2.4 Global Reverse Transcriptase Sales by Region
2.4.1 Global Reverse Transcriptase Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Reverse Transcriptase Sales by Region (2019-2024)
2.4.3 Global Reverse Transcriptase Sales by Region (2025-2030)
2.4.4 Global Reverse Transcriptase Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Reverse Transcriptase Sales by Manufacturers
3.1.1 Global Reverse Transcriptase Sales by Manufacturers (2019-2024)
3.1.2 Global Reverse Transcriptase Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Reverse Transcriptase in 2023
3.2 Global Reverse Transcriptase Revenue by Manufacturers
3.2.1 Global Reverse Transcriptase Revenue by Manufacturers (2019-2024)
3.2.2 Global Reverse Transcriptase Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Reverse Transcriptase Revenue in 2023
3.3 Global Key Players of Reverse Transcriptase, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Reverse Transcriptase Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Reverse Transcriptase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Reverse Transcriptase, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Reverse Transcriptase, Product Offered and Application
3.8 Global Key Manufacturers of Reverse Transcriptase, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Reverse Transcriptase Sales by Type
4.1.1 Global Reverse Transcriptase Historical Sales by Type (2019-2024)
4.1.2 Global Reverse Transcriptase Forecasted Sales by Type (2025-2030)
4.1.3 Global Reverse Transcriptase Sales Market Share by Type (2019-2030)
4.2 Global Reverse Transcriptase Revenue by Type
4.2.1 Global Reverse Transcriptase Historical Revenue by Type (2019-2024)
4.2.2 Global Reverse Transcriptase Forecasted Revenue by Type (2025-2030)
4.2.3 Global Reverse Transcriptase Revenue Market Share by Type (2019-2030)
4.3 Global Reverse Transcriptase Price by Type
4.3.1 Global Reverse Transcriptase Price by Type (2019-2024)
4.3.2 Global Reverse Transcriptase Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Reverse Transcriptase Sales by Application
5.1.1 Global Reverse Transcriptase Historical Sales by Application (2019-2024)
5.1.2 Global Reverse Transcriptase Forecasted Sales by Application (2025-2030)
5.1.3 Global Reverse Transcriptase Sales Market Share by Application (2019-2030)
5.2 Global Reverse Transcriptase Revenue by Application
5.2.1 Global Reverse Transcriptase Historical Revenue by Application (2019-2024)
5.2.2 Global Reverse Transcriptase Forecasted Revenue by Application (2025-2030)
5.2.3 Global Reverse Transcriptase Revenue Market Share by Application (2019-2030)
5.3 Global Reverse Transcriptase Price by Application
5.3.1 Global Reverse Transcriptase Price by Application (2019-2024)
5.3.2 Global Reverse Transcriptase Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Reverse Transcriptase Market Size by Type
6.1.1 US & Canada Reverse Transcriptase Sales by Type (2019-2030)
6.1.2 US & Canada Reverse Transcriptase Revenue by Type (2019-2030)
6.2 US & Canada Reverse Transcriptase Market Size by Application
6.2.1 US & Canada Reverse Transcriptase Sales by Application (2019-2030)
6.2.2 US & Canada Reverse Transcriptase Revenue by Application (2019-2030)
6.3 US & Canada Reverse Transcriptase Market Size by Country
6.3.1 US & Canada Reverse Transcriptase Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Reverse Transcriptase Sales by Country (2019-2030)
6.3.3 US & Canada Reverse Transcriptase Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Reverse Transcriptase Market Size by Type
7.1.1 Europe Reverse Transcriptase Sales by Type (2019-2030)
7.1.2 Europe Reverse Transcriptase Revenue by Type (2019-2030)
7.2 Europe Reverse Transcriptase Market Size by Application
7.2.1 Europe Reverse Transcriptase Sales by Application (2019-2030)
7.2.2 Europe Reverse Transcriptase Revenue by Application (2019-2030)
7.3 Europe Reverse Transcriptase Market Size by Country
7.3.1 Europe Reverse Transcriptase Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Reverse Transcriptase Sales by Country (2019-2030)
7.3.3 Europe Reverse Transcriptase Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Reverse Transcriptase Market Size
8.1.1 China Reverse Transcriptase Sales (2019-2030)
8.1.2 China Reverse Transcriptase Revenue (2019-2030)
8.2 China Reverse Transcriptase Market Size by Application
8.2.1 China Reverse Transcriptase Sales by Application (2019-2030)
8.2.2 China Reverse Transcriptase Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Reverse Transcriptase Market Size by Type
9.1.1 Asia Reverse Transcriptase Sales by Type (2019-2030)
9.1.2 Asia Reverse Transcriptase Revenue by Type (2019-2030)
9.2 Asia Reverse Transcriptase Market Size by Application
9.2.1 Asia Reverse Transcriptase Sales by Application (2019-2030)
9.2.2 Asia Reverse Transcriptase Revenue by Application (2019-2030)
9.3 Asia Reverse Transcriptase Sales by Region
9.3.1 Asia Reverse Transcriptase Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Reverse Transcriptase Revenue by Region (2019-2030)
9.3.3 Asia Reverse Transcriptase Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Reverse Transcriptase Market Size by Type
10.1.1 Middle East, Africa and Latin America Reverse Transcriptase Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Reverse Transcriptase Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Reverse Transcriptase Market Size by Application
10.2.1 Middle East, Africa and Latin America Reverse Transcriptase Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Reverse Transcriptase Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Reverse Transcriptase Sales by Country
10.3.1 Middle East, Africa and Latin America Reverse Transcriptase Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Reverse Transcriptase Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Reverse Transcriptase Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher Overview
11.1.3 Thermo Fisher Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Thermo Fisher Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Thermo Fisher Recent Developments
11.2 Promega
11.2.1 Promega Company Information
11.2.2 Promega Overview
11.2.3 Promega Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Promega Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Promega Recent Developments
11.3 Roche
11.3.1 Roche Company Information
11.3.2 Roche Overview
11.3.3 Roche Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Roche Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Bio-Rad
11.4.1 Bio-Rad Company Information
11.4.2 Bio-Rad Overview
11.4.3 Bio-Rad Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bio-Rad Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bio-Rad Recent Developments
11.5 Takara Bio
11.5.1 Takara Bio Company Information
11.5.2 Takara Bio Overview
11.5.3 Takara Bio Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Takara Bio Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takara Bio Recent Developments
11.6 Agilent
11.6.1 Agilent Company Information
11.6.2 Agilent Overview
11.6.3 Agilent Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Agilent Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Agilent Recent Developments
11.7 Qiagen
11.7.1 Qiagen Company Information
11.7.2 Qiagen Overview
11.7.3 Qiagen Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Qiagen Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Qiagen Recent Developments
11.8 Fapon Biotech
11.8.1 Fapon Biotech Company Information
11.8.2 Fapon Biotech Overview
11.8.3 Fapon Biotech Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Fapon Biotech Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Fapon Biotech Recent Developments
11.9 Toyobo
11.9.1 Toyobo Company Information
11.9.2 Toyobo Overview
11.9.3 Toyobo Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Toyobo Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Toyobo Recent Developments
11.10 Vazyme
11.10.1 Vazyme Company Information
11.10.2 Vazyme Overview
11.10.3 Vazyme Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Vazyme Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Vazyme Recent Developments
11.11 New England Biolabs
11.11.1 New England Biolabs Company Information
11.11.2 New England Biolabs Overview
11.11.3 New England Biolabs Reverse Transcriptase Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 New England Biolabs Reverse Transcriptase Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 New England Biolabs Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Reverse Transcriptase Industry Chain Analysis
12.2 Reverse Transcriptase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Reverse Transcriptase Production Mode & Process
12.4 Reverse Transcriptase Sales and Marketing
12.4.1 Reverse Transcriptase Sales Channels
12.4.2 Reverse Transcriptase Distributors
12.5 Reverse Transcriptase Customers
13 Market Dynamics
13.1 Reverse Transcriptase Industry Trends
13.2 Reverse Transcriptase Market Drivers
13.3 Reverse Transcriptase Market Challenges
13.4 Reverse Transcriptase Market Restraints
14 Key Findings in The Global Reverse Transcriptase Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs
Ìý
Ìý
*If Applicable.